COL4A4 and chronic kidney disease: Since patients with heterozygous mutations of COL4A3 or COL4A4 have shown a wide spectrum of disease from TBMN to ADAS, a systematic review has been performed and shown that 29% developed chronic kidney disease (CKD) and 15.1% reached end-stage kidney disease (ESKD) [2].